Default company panoramic image
A4be42a8 b97b 41f7 8e21 830cd53b91d9


ABS has developed and is selling a substitute for a total knee replacement using a minimally invasive outpatiet setting at 1/3rd the cost.

  • Stage $500K in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Minnetonka, MN, USA
  • Currency USD
  • Founded November 2008
  • Employees 6
  • Website

Company Summary

ABS's CE Marked knee implant is being used in Canada, Europe and India in place of total knee replacements. Patients prefer outpatient to 3 to 5 days of hospitalization at 1/3rd the cost. Insurers and government health plans like the lower cost and freeing up hospital beds. Orthopedic surgeons like the option as a total knee replacement is permanent even if the replacement is a failure. ABS seeks funding to expand international marketing.


  • Default avatar
    Jeffrey C. Felt
    Chairman and CTO

    Dr. Felt isa founding fellow of the American College of Rheumatology, a founder of Advanced Bio-Surfaces, Disc Dynamics and Vertebral Technologies, and is lead author of many ABS, DDI and VTI patents. Dr. Felt has personally invested $493,000 in ABS

  • Default avatar
    Warren Bielke
    President and CEO

    Former President of Medtronic InStent. founder of InStent, which Medtronic acquired. Exec VP of Pentax Precision Instrument Corp.Medical sales at Xomed Medical and Baxter Travenol. Mr. Bielke has personally invested $437,000 in ABS. Total management investment in ABS $1.8MM.

  • Default avatar
    Trevor J. Lee
    VP finance and Administration

    CFO Engineering Solutions Group. Finance Manager, VTI and Advanced Bio Surfaces. Certified Management Accountant. MBA

  • Default avatar
    Sandy A. von Stackelberg
    International Sales VP

    Medical device sales, Boston Scientific (Turkey, Central Europe, India). HydroCision managed sales in 27 countries. Multi lingual. MBA